Med-Fine Capital, with offices in Shanghai and Beijing, specializes in investments in healthcare and life sciences. Our management team boasts a global perspective, deep industry expertise, extensive resources, and professional investment experience. We manage several RMB funds and USD funds, focusing on early-stage value and on-track opportunities discovery in biotech, device, diagnostics, digital and services.
To date, we have invested in approximately 70 companies, including Hanyu Medical, Mabworks, ImmVira Pharma, Zion Pharma, LYNK Pharmaceuticals, Eccogene, Pharma Legacy, MagAssist, Alebund, Allorion Therapeutics, SAFE Pharmaceutical, Arthrone Technology, AccuPulse, and SMJH-Bio.
Guided by our vision "to be the bridge between nations and shape the future of life sciences" and our mission "to leverage capital to drive healthcare innovation," we uphold the values of "client first, talent first, quality first, and trust always.” By combining decentralized investment with systematic operation, Med-Fine Capital is dedicated to becoming a leading, platform-based international investment institution with exceptional competitiveness and a strong reputation.
Company Details
- Employees
- 10
- Founded
- -
- Address
- Shanghai Suite 3605-08, Shanghai Sk Tower, 150 Yaoyuan Road , Pudong New District, Shanghai Prc, Shanghai,china 200030,china
- Industry
- Investment Management
- NAICS
-
Other Financial Investment ActivitiesPortfolio ManagementAll Other Financial Investment ActivitiesTrust, Fiduciary, and Custody ActivitiesMiscellaneous Financial Investment Activities
- Website
- https://www.medfinecapital.com/
- Keywords
- Biotechnology, Healthcare Investment, Healthcare, Financial Services, Fund Management, Investment Management.
- HQ
- Shanghai, China
Med-Fine Capital Questions
Med-Fine Capital's website is https://www.medfinecapital.com/
Med-Fine Capital's LinkedIn profile is https://cn.linkedin.com/company/med-fine-capital
Med-Fine Capital has
10 employees.
View email and phone details for 10
employees at Med-Fine Capital.
Med-Fine Capital's industry is
Investment Management
Med-Fine Capital's top competitors are
Hankang Capital,
Boyu Capital,
Hike Capital,
Yunqi Partners,
Shenzhen Capital Group Co., Ltd,
Jifeng Ventures 济峰资本,
惠每资本,
合碳智能c12.ai,
Ferrystory,
Hillhouse Investment.
Med-Fine Capital's categories are Investment Management
Med-Fine Capital's founding year is 2014
